Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer

Prostate

Volumn 41, Issue 3, 1999, Pages 190-195

  Hyytinen, Eija Riitta ^a   Frierson Jr , Henry F ^a   Sipe, Tavis W ^a   Li, Chang Ling ^a   Degeorges, Armelle ^a   Sikes, Robert A ^a   Chung, Leland W K ^a   Dong, Jin Tang ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

ERCC5; Gene mutations; Loss of heterozygosity; Prostate cancer; XPG

Indexed keywords

AMINO ACID; DNA;

AMINO ACID SEQUENCE; ARTICLE; CARCINOGENESIS; CHROMOSOME 13Q; DNA REPAIR; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; SEQUENCE ANALYSIS; XERODERMA PIGMENTOSUM;

ADULT; AGED; AMINO ACID SEQUENCE; CHROMOSOMES, HUMAN, PAIR 13; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA-BINDING PROTEINS; ENDONUCLEASES; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0032734709     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19991101)41:3<190::AID-PROS6>3.0.CO;2-2     Document Type: Article

References (32)

1. Bohr VA, Phillips DH, Hanawalt PC. Heterogeneous DNA damage and repair in the mammalian genome. Cancer Res 1987;47: 6426-6436.
2. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-1308.
3. Sancar A. DNA excision repair. Annu Rev Biochem 1996;65:43-81.
4. Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ. Nucleotide excision repair syndromes: xeroderma pigmentaosum, cockayne syndrome, and trichothiodystrophy. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 1998. p 245-273.
5. Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968;218:652-656.
6. Habraken Y, Sung P, Prakash L, Prakash S. Human xeroderma pigmentosum group G gene encodes a DNA endonuclease. Nucleic Acids Res 1994;22:3312-3316.
7. O'Donovan A, Wood RD. Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC group 5. Nature 1993;363:185-188.
8. O'Donovan A, Davies AA, Moggs JG, West SC, Wood RD. XPG endonuclease makes the 3′ incision in human DNA nucleotide excision repair. Nature 1994;371:432-435.
9. Cloud KG, Shen B, Strniste GF, Park MS. XPG protein has a structure-specific endonuclease activity. Mutat Res 1995;347:55-60.
10. Nouspikel T, Clarkson SG. Mutations that disable the DNA repair gene XPG in a xeroderma pigmentosum group G patient. Hum Mol Genet 1994;3:963-967.
11. Nouspikel T, Lalle P, Leadon SA, Cooper PK, Clarkson SG. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function. Proc Natl Acad Sci USA 1997;94:3116-3121.
12. Okinaka RT, Perez-Castro AV, Sena A, Laubscher K, Strniste GF, Park MS, Hernandez R, MacInnes MA, Kraemer KH. Heritable genetic alterations in a xeroderma pigmentosum group G/Cockayne syndrome pedigree. Mutat Res 1997;385:107-114.
13. Scherly D, Nouspikel T, Corlet J, Ucla C, Bairoch A, Clarkson SG. Complementation of the DNA repair defect in xeroderma pigmentosum group G cells by a human cDNA related to yeast RAD2. Nature 1993;363:182-185
14. Shiomi T, Harada Y, Satio T, Shiomi N, Okuno Y, Yamaizumi M. An ERCC5 gene with homology to yeast RAD2 is involved in group G xeroderma pigmentosum. Mutat Res 1994;314:167-175.
15. Samec S, Clarkson SG, Blaschak J, Chakravarti A, Morris MA, Scherly D, Antonarakis SE. Dinucleotide repeat polymorphism within ERCC5 gene. Hum Mol Genet 1994;3:214.
16. Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silva J, Slonim DK, Baptista R, Kruglyak L, Xu SH, Hu X, Colbert AME, Rosenberg C, Reeve-Daly MP, Rozen S, Hui L, Wu X, Vestergaard C, Wilson KM, Bae JS, Maitra S, Ganiatsas S, Evans CA, DeAngelis MM, Ingalls KA, Nahf RW, Horton LT, Anderson MO, Collymore AJ, Ye W, Kouyoumjian V, Zemsteva IS, Tam J, Devine R, Courrney DF, Renaud TM, Nguyen H, O'Connor TJ, Fizames C, Faure S, Gyapay G, Dib C, Morissette J, Orlin JB, Birren BW, Goodman N, Weissenbach J, Hawkins TL, Foote S, Page DC, Lander ES. An STS-based map of the human genome. Science 1995;270:1945-1954 (with supplementary data from the Whitehead Institute/MIT Center for Genome Research, Human Genetic Mapping project, data release 12, July 1997).
17. Cayanis E, Russo JJ, Kalachikov S, Ye X, Park SH, Sunjevaric I, Bonaldo MF, Lawton L, Venkatraj VS, Schon E, Soares MB, Rothstein R, Warburton D, Edelman IS, Zhang P, Efstratiadis A, Fischer SG. High-resolution YAC-cosmid-STS map of human chromosome 13. Genomics 1998;47:26-43.
18. Hyytinen ER, Frierson HF, Boyd JC, Chung LWK, Dong JT. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer. Gene Chromosome Cancer 1999; 25:108-114.
19. American Joint Committee Cancer. AJCC cancer staging manual, 5th ed. Philadelphia: Lippincott-Raven; 1997. 294 p.
20. Moskaluk CA, Kern SE. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 1997;150:1547-1552.
21. Zhau HY, Chang SM, Chen BQ, Wang Y, Zhang H, Kao C, Sang QA, Pathak SJ, Chung LW. Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci USA 1996;93:15152-15157.
22. Samec S, Jones TA, Corlet J, Scherly D, Sheer D, Wood RD, Clarkson SG. The human gene for xeroderma pigmentosum complementation group C (XPG) maps to 13q33 by fluorescence in situ hybridization. Genomics 1994;21:283-285.
23. Ludwig DL, Mudgett JS, Park MS, Perez-Castro AV, MacInnes MA. Molecular cloning and structural analysis of the functional mouse genomic XPG gene. Mamm Genome 1996;7:644-649.
24. Kukita Y, Tahira T, Sommer SS, Hayashi K. SSCP analysis of long DNA fragments in low pH gel. Hum Mutat 1997;10:400-407.
25. Dong JT, Sipe TW, Hyytinen ER, Li CL, Heise C, McClintock DE, Grant CD, Chung LW, Frierson HF Jr. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate. Oncogene 1998;17:1979-1982.
26. Hyytinen ER, Thalmann GN, Zhau HE, Karhu R, Kallioniemi OP, Chung LWK, Visakorpi T. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastaric potential in a prostate cancer model. Br J Cancer 1997;75:190-195.
27. Nupponen NN, Kakkola L, Koivisto P, Visakorpi T. Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 1998;153:141-148.
28. Nupponen NN, Hyytinen ER, Kallioniemi AH, Visakorpi T. Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization. Cancer Genet Cytogenet 1998; 101:53-57.
29. Maestro R, Piccinin S, Doglioni C, Gasparotto D, Vukosavljevic T, Sulfaro S, Barzan L, Boiocchi M. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res 1996;56:1146-1150.
30. Yang-Feng TL, Li S, Han H, Schwartz PE. Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer. Int J Cancer 1992;52:575-580.
31. Mohrenweiser HW, Jones IM. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat Res 1998;400:15-24.
32. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604-608.